✦ LIBER ✦

Phase I/II study of CT-2103 (Xyotax) in patients with recurrent ovarian cancer

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of Xyotax (CT-2103) in pa

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I study of Xyotax (CT-2103) and ci

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I study of Xyotax (CT-2103) and ca

📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 157 KB

Phase I study of the novel taxane CT-210

✍ Maria Luisa Veronese; Keith Flaherty; Amy Kramer; Barbara A. Konkle; Mark Morgan 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 223 KB

A Phase II, open-label study evaluating

✍ Michael Friedlander; Kenneth C. Hancock; Danny Rischin; Mark J. Messing; Claude 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Phase II study of weekly topotecan in pa

✍ Tally Levy; Moshe Inbar; Joseph Menczer; Dan Grisaru; Marek Glezerman; Tamar Saf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 140 KB